Genotype and Phenotype Analysis in X-Linked Hypophosphatemia.

Area of Science:

• Genetics
• Pediatrics
• Endocrinology

Background:

• X-linked hypophosphatemia (XLH) is the most common inherited form of rickets.
• It is caused by mutations in the phosphate-regulating gene, PHEX.
• Understanding genotype-phenotype correlations is crucial for XLH patient management.

Purpose of the Study:

• To analyze genotype-phenotype correlations in XLH patients with confirmed PHEX mutations.
• To compare clinical findings between patients with truncating and nontruncating PHEX mutations.
• To assess long-term disease manifestations and prognosis based on mutation type.

Main Methods:

• PHEX mutations were identified in 81 patients with hypophosphatemic rickets.
• Patients were categorized into nontruncating (n=9) and truncating (n=46) mutation groups.
• Initial and long-term clinical data, including laboratory results and surgical history, were evaluated.

Main Results:

• Initial presentations were similar between groups, but long-term follow-up revealed significant differences.
• Patients with truncating mutations had lower serum phosphate levels (2.3 mg/dL vs. 3.2 mg/dL).
• Nephrocalcinosis occurred in 62.5% of truncating mutation patients, versus none in the nontruncating group. Orthopedic surgery was also more frequent in the truncating group (52.3% vs. 10.0%).

Conclusions:

• A genotype-phenotype correlation exists in XLH, particularly evident in long-term outcomes.
• Truncating PHEX mutations are associated with more severe disease manifestations, including lower phosphate levels, nephrocalcinosis, and need for orthopedic surgery.
• This genotype-specific information aids in counseling XLH patients regarding their prognosis.